The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.

Vannice, Kirsten S; Hills, Susan L; Schwartz, Lauren M; Barrett, Alan D; Heffelfinger, James; Hombach, Joachim; Letson, G William; Solomon, Tom; Marfin, Anthony A

Vannice, Kirsten S; Hills, Susan L; Schwartz, Lauren M; Barrett, Alan D; Heffelfinger, James; Hombach, Joachim; Letson, G William; Solomon, Tom; Marfin, Anthony A.

Afiliación

Vannice KS; Consultant, PATH, Seattle, WA, USA.
Hills SL; Arboviral Diseases Branch, Centers for Disease Control and Prevention, Fort Collins, CO, USA.
Schwartz LM; Schwartz Consulting, Seattle, WA, USA.
Barrett AD; Sealy Institute for Vaccine Sciences, Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Heffelfinger J; WHO Regional Office for the Western Pacific, Manila, Philippines.
Hombach J; Department of Immunizations, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
Letson GW; PATH, Seattle, WA, USA.
Solomon T; National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, and Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Marfin AA; Walton Centre NHS Foundation Trust, Liverpool, UK.

NPJ Vaccines ; 6(1): 82, 2021 Jun 15.

Article en En | MEDLINE | ID: mdl-34131150

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: NPJ Vaccines Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google